loading...

Contact| FAQ
Submit a request

Quick Inventory of Depressive Symptomatology (QIDS-SR and QIDS-C)

Rush AJ

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Derived from the Inventory of Depressive Symptomatology (IDS-SR and IDS-C) in 2003

WEBINAR: An Author Webinar on the Quick Inventory of Depressive Symptomatology - Recorded session available soon.

Authors

Rush AJ

Copyright
QIDS © 1986, 2000 UT Southwestern Medical Center, Dallas
Objective
To assess depressive symptom severity

[ These assessments can be used to screen for depression, although they have been used predominantly as measures of symptom severity ]
Therapeutic area
  • Behavior and Behavior Mechanisms
Therapeutic indication

Depression

Type of Clinical Outcome Assessment (COA)
  • clinro ClinRO
  • pro PRO
ClinRO: QIDS-C; PRO: QIDS-SR
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003 Sep 1;54(5):573-83. Erratum in: Biol Psychiatry. 2003 Sep 1;54(5):585 (PubMed abstract)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Rush AJ

John Rush
E-mail: curbstoneconsultant@gmail.com

John Rush publications (PubMed)

 

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access the questionnaire and/or its available translations directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

QIDS-C

Arabic for Saudi Arabia
Dutch for the Netherlands
Spanish for Spain*
Turkish for Turkey

QIDS-SR 16

Afrikaans for South Africa*
Arabic for Israel
Arabic for Saudi Arabia*
Bulgarian for Bulgaria*
Cantonese for Hong Kong
Chinese for Taiwan
Croatian for Croatia*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for Hong Kong*
English for India*
English for Israel
English for South Africa*
English for the UK*
Estonian for Estonia*
Finnish for Finland*
French for Belgium*
French for Canada*
French for France*
French for Switzerland
Georgian for Georgia*
German for Austria*
German for Germany*
German for Switzerland
Gujarati for India*
Hebrew for Israel*
Hindi for India*
Hungarian for Hungary*
Icelandic for Iceland
Italian for Italy*
Italian for Switzerland
Japanese for Japan*
Kannada for India*
Korean for Korea*
Latvian for Latvia*
Lithuanian for Lithuania*
Macedonian for Macedonia
Malay for Singapore*
Malayalam for India*
Mandarin Chinese for HONG KONG*
Mandarin for China*
Marathi for India*
Norwegian for Norway*
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Punjabi for India*
Romanian for Romania*
Russian for Estonia*
Russian for Latvia*
Russian for Lithuania*
Russian for Russia*
Russian for Ukraine*
Serbian for Serbia*
Slovak for Slovakia*
Spanish for Argentina*
Spanish for Chile*
Spanish for Colombia*
Spanish for Costa Rica*
Spanish for Ecuador*
Spanish for Mexico*
Spanish for Peru*
Spanish for Puerto Rico
Spanish for Spain*
Spanish for the USA*
Swedish for Finland*
Swedish for Sweden*
Tamil for India*
Telugu for India*
Turkish for Turkey*
Ukrainian for Ukraine*
Urdu for India
Zulu for South Africa*
* Performed by Mapi

Conditions to translate

Recommended vendor for translation work: Mapi/ICON Language Services

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

E-versions

Implemented electronically on P1vital Products Limited ePRO Clinical

Please see the ePRO Clinical webpage

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

MORE INFORMATION Subscribe NOW
A question? Contact us

YOU MIGHT ALSO BE INTERESTED IN:

PROLABELS: 1 indication